| Financial Year |
March 31 2023 |
| Monetary Funds |
195,892,563.43 |
| Held-for-trading Financial Assets |
26,791,000.00 |
| Notes Receivable |
18,596,669.41 |
| Accounts Receivable |
208,511,569.03 |
| Advances to Suppliers |
42,967,424.74 |
| Other Receivables |
44,464,130.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
18,791,900.00 |
| Inventories |
854,351,441.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,325,000.12 |
| Total Current Assets |
1,445,048,435.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
132,159,139.81 |
| Investment Properties |
496,045,644.57 |
| Fixed Assetes |
170,023,533.96 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
169,727,161.37 |
| R&D expenses |
31,282,928.59 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,623,254.86 |
| Deferred Income Tax Assets |
25,726,820.63 |
| Other Non-Current Assets |
12,713,909.01 |
| Sub-Total of Non-Current Assets |
1,287,982,706.89 |
| Total Assets |
2,733,031,142.06 |
| Short-Term Loans |
600,234,615.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,130,670.00 |
| Accounts Payable |
258,633,720.12 |
| Accounts Received In Advance |
7,503,118.59 |
| Employee Compensation Payable |
5,991,959.77 |
| Taxes Payable |
6,569,301.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,156,192.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,380,427.74 |
| Other Current Liabilities |
27,460,180.94 |
| Sub-Total of Current Liabilities |
1,022,587,860.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,311,531.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
109,302,367.14 |
| Total Liabilities |
1,131,890,227.74 |
| Paid-In Capital(Or Share Stock) |
622,200,000.00 |
| Capital Surplus |
361,509,872.14 |
| Surplus Reserve |
78,025,005.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
472,497,642.51 |
| Minority Stockholder's Interest |
1,880,068.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,599,260,845.51 |
| Owner's Equity（Stockholder's Equity） |
1,601,140,914.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,733,031,142.06 |
